Mechanism of Histone Deacetylase Inhibitors for Treatment of Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis(IPF) is a chronic, progressive, and fibrotic interstitial lung disease. In recent years, with the in-depth study of the pathological mechanism of IPF, more and more drug treatment targets for IPF have been discovered. Studies have shown that the dysregulation of epigene...
Saved in:
| Main Authors: | ZHOU Jia, LI Long, LIAO Jing |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Medical Journal of Peking Union Medical College Hospital
2025-02-01
|
| Series: | Xiehe Yixue Zazhi |
| Subjects: | |
| Online Access: | https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2024-0415 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design, synthesis, and biological evaluation of novel histone deacetylase 6 selective inhibitors
by: Tianyi Zhang, et al.
Published: (2022-05-01) -
Design and synthesis of thiazole-based hydroxamate histone deacetylase inhibitors with potent antitumor efficacy by inducing apoptosis, pyroptosis and cell cycle arrest
by: Zhijian Li, et al.
Published: (2025-07-01) -
Targeting E3 ubiquitin ligases: a new frontier in idiopathic pulmonary fibrosis treatment
by: Kun Zhang, et al.
Published: (2025-08-01) -
Exploring the potential of Gonolobus condurango as a histone deacetylase inhibitor in triple-negative breast cancer cell lines: in vitro study
by: Beate Vajen, et al.
Published: (2025-05-01) -
A missense mutation in the Sin3 subunit of Rpd3 histone deacetylase complex bypasses the requirement for FNG1 in wheat scab fungus
by: Huaijian Xu, et al.
Published: (2025-08-01)